Xenetic Biosciences (XBIO) Enterprise Value (2023 - 2025)
Xenetic Biosciences (XBIO) has disclosed Enterprise Value for 5 consecutive years, with -$4.1 million as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Enterprise Value rose 39.74% year-over-year to -$4.1 million, compared with a TTM value of -$4.1 million through Sep 2025, up 39.74%, and an annual FY2024 reading of -$6.2 million, up 31.36% over the prior year.
- Enterprise Value was -$4.1 million for Q3 2025 at Xenetic Biosciences, up from -$4.8 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$4.1 million in Q3 2025 and bottomed at -$12.0 million in Q1 2023.
- Average Enterprise Value over 3 years is -$7.6 million, with a median of -$7.3 million recorded in 2024.
- The sharpest move saw Enterprise Value soared 30.04% in 2024, then soared 39.74% in 2025.
- Year by year, Enterprise Value stood at -$9.0 million in 2023, then skyrocketed by 31.36% to -$6.2 million in 2024, then surged by 33.15% to -$4.1 million in 2025.
- Business Quant data shows Enterprise Value for XBIO at -$4.1 million in Q3 2025, -$4.8 million in Q2 2025, and -$5.2 million in Q1 2025.